Your browser doesn't support javascript.
loading
Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis.
Ivama-Brummell, Adriana M; Marciniuk, Fernanda L; Wagner, Anita K; Osorio-de-Castro, Claudia G S; Vogler, Sabine; Mossialos, Elias; Tavares-de-Andrade, Carla L; Naci, Huseyin.
Afiliação
  • Ivama-Brummell AM; Department of Health Policy, London School of Economics and Political Science, Cowdray House, Houghton Street, London, WC2A 2AE, United Kingdom.
  • Marciniuk FL; Office of Assessment of Safety and Efficacy, General Office of Medicines, Brazilian Health Regulatory Agency, SIA, Trecho 05, Área Especial 57, Brasília-DF CEP 71.205-050, Brazil.
  • Wagner AK; Executive Secretariat of the Drug Market Regulation Chamber, Brazilian Health Regulatory Agency, SIA, Trecho 05, Área Especial 57, Brasília-DF CEP 71.205-050, Brazil.
  • Osorio-de-Castro CGS; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA.
  • Vogler S; Department of Medicines Policy and Pharmaceutical Services, Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rua Leopoldo Bulhões, 1480, sala 632, Manguinhos, Rio de Janeiro, RJ, 21041-210, Brazil.
  • Mossialos E; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Austrian National Public Health Institute, Stubenring 6, Vienna, 1010, Austria.
  • Tavares-de-Andrade CL; Department of Health Care Management, Technical University of Berlin, Berlin, 10623, Germany.
  • Naci H; Department of Health Policy, London School of Economics and Political Science, Cowdray House, Houghton Street, London, WC2A 2AE, United Kingdom.
Lancet Reg Health Am ; 22: 100506, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37235087
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude / 1_medicamentos_vacinas_tecnologias Tipo de estudo: Clinical_trials / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Risk_factors_studies País/Região como assunto: America do sul / Brasil Idioma: En Revista: Lancet Reg Health Am Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude / 1_medicamentos_vacinas_tecnologias Tipo de estudo: Clinical_trials / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Risk_factors_studies País/Região como assunto: America do sul / Brasil Idioma: En Revista: Lancet Reg Health Am Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido